Christopher Locher

CEO & Co-Founder at Versatope, USA

Speaker

Christopher P. Locher, PhD is the CEO and a co-founder of Versatope Therapeutics, a clinical-stage Massachusetts-based company currently focused on the development of immunotherapeutics using nano-vesicles. He previously led drug discovery projects at Vertex Pharmaceuticals in Boston, inflammatory diseases at Opsona Therapeutics in Ireland and malaria and alphaviruses vaccines at Maxygen in California. He completed postdoctoral training at the University of California, San Francisco, was a Fulbright Hays Research Fellow at the Institute of Tropical Medicine in Antwerp, Belgium and received his PhD in Tropical Medicine and BA in Biological Sciences from the University of Hawai`i.